Jeremy Tran

Jeremy Tran serves as a procurement specialist within the National Institute on Drug Abuse (NIDA), supporting the agency’s mission to advance scientific research on substance use disorders through strategic acquisition of specialized scientific and technical resources. He manages a diverse portfolio of research-supporting contracts, primarily focused on procuring laboratory instrumentation, biomedical devices, and data analytics platforms essential to neurobiological and behavioral research. His work bridges the gap between scientific discovery and operational capability, ensuring that NIDA-funded institutions have access to cutting-edge tools for translational research and clinical application. Tran maintains strong, long-term relationships with leading academic and research institutions, including McLean Hospital Corporation, the University of Maryland Baltimore, the University of Miami, the University of Pittsburgh, and the Icahn School of Medicine at Mount Sinai. These partnerships reflect a preference for high-capacity research organizations capable of deploying complex instrumentation and conducting multi-site clinical studies. His contracting approach emphasizes compliance with federal research standards and the integration of validated scientific methodologies into procurement specifications. His procurement patterns show a strong emphasis on open competition, with 90% of acquisitions conducted without set-asides, reflecting the technical complexity and scale of requirements. However, he consistently allocates 10% of opportunities to total small business set-asides under FAR 19.5, demonstrating a measured commitment to small business participation without compromising scientific rigor. Tran’s primary NAICS focus areas include analytical laboratory instrument manufacturing (334516) and electromedical device manufacturing (334510), indicating deep expertise in procuring neuroimaging equipment, addiction monitoring systems, and precision diagnostic tools. He also regularly acquires specialized plastics and data software services to support experimental protocols and data management infrastructure, underscoring his technical fluency in biomedical research procurement.